The largest database of trusted experimental protocols

29 protocols using sterile filter

1

Radiolabeled Compound Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard reagents and solvents were commercially available and used without further purification, unless otherwise noted: sodium chloride, 0.9% USP and sterile water for Injection, USP were purchased from Hospira; Dehydrated Alcohol for Injection, USP was obtained from Akorn Inc.; Ascorbic Acid for Injection, USP was acquired from Bioniche Pharma; molecular sieves were purchased from Alltech; and HPLC columns were acquired from Phenomenex. Other synthesis components were obtained as follows: sterile filters were acquired from Millipore; C18 Sep-Paks were purchased from Waters Corporation; 10 cc sterile vials were obtained from HollisterStier. Sep-Paks were flushed with 10 mL of ethanol followed by 10 mL of sterile water prior to use. [11C]CO2 was produced with a General Electric (GE) PETTrace cyclotron. High purity nitrogen containing 0.5% O2 was irradiated with 16.5 MeV to generate [11C]CO2, which was delivered to a GE TRACERlab FXC-Pro synthesis module via stainless steel lines. Radiochemical syntheses were carried out using GE TRACERLab FXC-Pro synthesis modules housed in Comecer hot-cells. Doses produced were assessed via standard quality control techniques (see below) and were appropriate for rodent studies.
+ Open protocol
+ Expand
2

Aflatoxin B1 Degradation by Strain N17-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of cell free supernatant, bacterial cells and intracellular cell extracts of strain N17-1 on reduction of AFB1 were studied according to method as described previously [16 (link),22 (link),36 (link)]. Strain N17-1 was pre-cultivated in 4 mL NB at 37 °C for 12 h agitation at 180 rpm, and 1 mL of the culture was transferred to 100 mL of the same medium. After cultivation at 37 °C with shaking at 180 rpm for 48 h, the cells were harvested by centrifugation (5000× g, 10 min, 4 °C). The supernatant was collected and tested for AFB1 degradation.
The pellets were washed twice with phosphate buffer (50 mM, pH 7.0) before re-suspended in the phosphate buffer. The AFB1 degradation analysis was performed as described above. The phosphate buffer substituted bacterial cell suspensions in control.
Pellets were suspended in phosphate buffer (50 mM, pH 7.0; 3 mL buffer per gram cell mass). The suspension was disintegrated by using ultrasonic cell disintegrator (Ningbo Xinzhi Instruments Inc., Ningbo, China). The suspension was centrifuged at 12,000 g for 10 min at 4 °C. The supernatant was filtered aseptically using sterile filters of 0.22 μm pore size (Millipore, Darmstadt, Germany). The AFB1 degradation tests were performed as described above. Phosphate buffer substituted intracellular cell extracts in control.
+ Open protocol
+ Expand
3

Ethanolic Extraction of Propolis and Bee Pollen

Check if the same lab product or an alternative is used in the 5 most similar protocols
The procedure described by Dziedzic et al. (2013) [20 (link)] with modifications was used to prepare an ethanolic extract of propolis and ethanolic extract bee pollen. Crushed propolis (40g) or bee pollen (40 g) (apiary, Poland) was mixed with 96.0% ethanol (100ml). The suspensions were stored in the darkness at room temperature (25°C) with shaking (200 rpm, 6 hours per day) for 4 days. Then the infusion was placed at -20°C for precipitating alcohol insoluble compounds of propolis. After 24 hours, the resulting infusion was filtrated through sterile filters (0.45 μm, Millipore). The 40.0% EEP and 40.0% EEBP were stored at room temperature (25°C).
+ Open protocol
+ Expand
4

Oligo-fucoidan Extraction and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fucoidan powder from Laminaria japonica, a commercial product named Hi-Q Oligo-fucoidan®, was provided by Hi-Q Marine Biotech International Ltd. (New Taipei City, Taiwan). Briefly, the crude extract of Laminaria japonica was eluted with a NaCl gradient on a DEAE (Diethylaminoethyl)-Sephadex A-25 column. The fucose- and sulfate-enriched fraction eluted at a higher concentration of NaCl was collected and then hydrolyzed with glycolytic enzyme preparation to obtain our oligo-fucoidan (OF) sample [54 (link)]. The characteristics of oligo-fucoidan (OF) were as follows: average molecular weight of <667 Da with a 85.9% fucose content (127.2 ± 1.3 μmol/g), sulfate content 28.4% ± 2.1% (w/w), protein content 4.3% ± 0.3% (w/w), fat content 0.6% ± 0.1% (w/w), ash 4.1% ± 0.1% (w/w) and moisture content 3.9% ± 0.8% (w/w) [29 (link)]. It was dissolved in double-distilled H2O and stirred at 25 °C for 30 min. The dissolved solution was filtered using 0.22 μm sterile filters (Millipore, Billerica, MA, USA). decitabine (5-aza-2′-deoxycytidine, Cat #A3656, Sigma-Aldrich, St Louis, MO, USA) was used as a demethylating agent. Stock solutions of decitabine (20 mM) were dissolved in dimethyl sulfoxide (Cat #D2650, Sigma-Aldrich).
+ Open protocol
+ Expand
5

Preparation of Sterile Pharmaceutical Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, reagents and solvents were commercially available and used without further purification: Sodium Chloride, 0.9% USP and Sterile Water for Injection, USP were purchased from Hospira; ethanol was purchased from American Regent; HPLC grade acetonitrile was purchased from Fisher Scientific. Other synthesis components were obtained as follows: sterile filters were obtained from Millipore; sterile product vials were purchased from Hollister-Stier; QMA-light and C18-light Sep-Paks® were purchased from Waters Corporation. Sep-Paks® were flushed with 10 mL of ethanol followed by 10 mL of sterile water prior to use.
+ Open protocol
+ Expand
6

Radiolabeled Compound Synthesis and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents and solvents were purchased from Aldrich Chemical or Fisher Scientific and were used without further purification unless noted. Chromatography columns for HPLC analysis and purification were purchased from Phenomenex or Waters. High performance liquid chromatography (HPLC) was performed using a Shimadzu LC-2010A HT system equipped with a Bioscan B- FC-1000 radiation detector. Sodium chloride, 0.9% USP and sterile water for Injection, USP were purchased from Hospira; Dehydrated Alcohol for Injection, USP was obtained from Akorn Inc. Sterile filters were acquired from Millipore; 10 cc sterile vials were obtained from Hollister-Stier; C18 sep-paks were purchased from Waters Corporation and were flushed with 10 ml of ethanol followed by 10 ml of sterile water prior to use. BCPP-EF reference standard 1 and labeling precursor 15 were synthesized in house. Detailed procedures are provided in the Supplementary Material.
+ Open protocol
+ Expand
7

Cytotoxicity Evaluation of Dental Materials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Test materials used in this study were ProRoot MTA white-colored formula (Dentsply Tulsa Dental, Tulsa, Oklahoma, USA) and NFC (Sanat Avaran Vista, Iran).
After sterilization with an ultraviolet beam, the materials were mixed according to the manufacturer's guidelines under aseptic conditions.
Freshly mixed materials were placed into the plastic molds with 5-mm diameter and 3-mm height, and then incubated at 37˚C and 95% humidity for 24 hours.
After complete setting, extracts of the materials were produced as follows: 5 ml of complete Dulbecco's Modified Eagle Medium
(DMEM; Sigma Chemical Co., St. Louis, MO, USA) containing 10% Fetal Bovine Serum (FBS; Gibco, Grand Island, NY, USA) was mixed with 1 mg of each test
material in sterile vials. The mixture was incubated at 37˚C at 100% relative humidity for 72 hours. The medium was then drawn off and
filtered using sterile filters at 0.22 µm (Millipore; Billerica, MA, USA). The extracts were serially diluted 1:2 with complete DMEM to
achieve a total of six concentrations of each extract (neat, 1/2, 1/4, 1/8, 1/16, 1/32).
The cells in DMEM served as the negative control group. DMEM alone, in 96 well tissue culture plates, were used as the positive control group.
+ Open protocol
+ Expand
8

Purification and Characterization of Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents and solvents were commercially available and used without further purification, unless otherwise noted: sodium chloride (0.9% USP) and sterile water for Injection (USP) were purchased from Hospira; Dehydrated Alcohol for Injection (USP) was obtained from Akorn Inc. Shimalite-Nickle was purchased from Shimadzu; iodine was obtained from EMD; phosphorus pentoxide was acquired from Fluka; molecular sieves were purchased from Alltech; and HPLC columns were acquired from Phenomenex. Other synthesis components were obtained as follows: sterile filters were acquired from Millipore; C18-light Sep-Paks and Porapak Q were purchased from Waters Corporation; 10 cc sterile vials were obtained from HollisterStier. Sep-Paks were flushed with 10 mL of ethanol followed by 10 mL of sterile water prior to use.
+ Open protocol
+ Expand
9

Preparation and Purification of Radiopharmaceuticals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, reagents and solvents were commercially available and used without further purification: Sodium Chloride, 0.9% USP and Sterile Water for Injection, USP were purchased from Hospira; ethanol was purchased from American Regent; HPLC grade acetonitrile was purchased from Fisher Scientific. Shimalite-Nickel was purchased from Shimadzu; iodine was purchased from EMD; phosphorus pentoxide was purchased from Fluka; and molecular sieves were purchased from Alltech; sterile filters were obtained from Millipore; sterile product vials were purchased from Hollister-Stier; C18 Sep-Paks and Porapak-Q were purchased from Waters Corporation. Sep-Paks were flushed with 10 mL of ethanol followed by 10 mL of sterile water prior to use.
+ Open protocol
+ Expand
10

Radiolabeled Compound Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, reagents and solvents were commercially available and used without further purification: sodium chloride, 0.9% USP, and sterile water for injection, USP, were purchased from Hospira; ethanol was purchased from American Regent; HPLC grade acetonitrile was purchased from Fisher Scientific. Other synthesis components were obtained as follows: sterile filters were obtained from Millipore; sterile product vials were purchased from Hollister-Stier; C18 Sep-Paks were purchased from Waters Corporation. C18 Sep-Paks were flushed with 10 mL of ethanol followed by 10 mL of water prior to use. Radio-HPLC was performed using a Shimadzu LC-2010A HT system equipped with a Bioscan B-FC-1000 radiation detector.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!